Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of E0302 SR vs IR Tablets in Healthy Subjects
NCT03885882Phase 1Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Apr 2019
- Primary completion
- Jun 2019
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of mecobalamin in peripheral neuropathy (4 arms), sponsored by Eisai Co., Ltd. Primary endpoints: Maximum Observed Plasma Concentration, Area Under the Concentration-Time Curve From Zero Time to Time of Last Quantifiable Concentration and 5 more. Started Apr 2019; status: completed.
02
Drugs
mecobalamin
03
Conditions
peripheral neuropathy
Beyond the preview
Go deeper on NCT03885882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03885882.